APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chicken Medicine and Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Chicken Medicine and Vaccines Market Analysis and Forecast 2026-2032

30 December 2025199 pages

Choose your research edition.

Industry ResearchChicken Medicine and Vaccines Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Chicken Medicine and Vaccines Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Chicken Medicine and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chicken Medicine and Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Chicken Medicine and Vaccines Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Chicken Medicine and Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Chicken Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Chicken Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Chicken Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Chicken Medicine and Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Chicken Medicine and Vaccines include CAVAC, CEVA, DHN, Elanco (Lohmann), FATRO, Merial, QYH Biotech, Ringpu Biology and Vaksindo, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Chicken Medicine and Vaccines, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Chicken Medicine and Vaccines, also provides the revenue of main regions and countries. Of the upcoming market potential for Chicken Medicine and Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Chicken Medicine and Vaccines revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Chicken Medicine and Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Chicken Medicine and Vaccines revenue, projected growth trends, production technology, application and end-user industry.

Chicken Medicine and Vaccines Segment by Company

CAVAC

CEVA

DHN

Elanco (Lohmann)

FATRO

Merial

QYH Biotech

Ringpu Biology

Vaksindo

Yebio

Zoetis

ChengDu Tecbond

Merck Animal Health

Harbin Veterinary Research Institute

Chicken Medicine and Vaccines Segment by Type

Medicine

Vaccines

Chicken Medicine and Vaccines Segment by Application

Farm

Government

Chicken Medicine and Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chicken Medicine and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chicken Medicine and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chicken Medicine and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Chicken Medicine and Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Chicken Medicine and Vaccines company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chicken Medicine and Vaccines revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Chicken Medicine and Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Medicine Major Player Table 3. Vaccines Major Player Table 4. Global Chicken Medicine and Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Farm Major Player Table 6. Government Major Player Table 7. Chicken Medicine and Vaccines Industry Trends Table 8. Chicken Medicine and Vaccines Industry Drivers Table 9. Chicken Medicine and Vaccines Industry Opportunities and Challenges Table 10. Chicken Medicine and Vaccines Industry Restraints Table 11. Global Chicken Medicine and Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Chicken Medicine and Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Chicken Medicine and Vaccines Market Share by Region (2021-2026) Table 14. Global Chicken Medicine and Vaccines Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Chicken Medicine and Vaccines Market Share by Region (2027-2032) Table 16. Global Chicken Medicine and Vaccines Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Chicken Medicine and Vaccines Revenue Market Share by Players (2021-2026) Table 18. Global Chicken Medicine and Vaccines Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Chicken Medicine and Vaccines Key Players Headquarters & Area Served Table 20. Global Chicken Medicine and Vaccines Players, Product Type & Application Table 21. Global Chicken Medicine and Vaccines Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Chicken Medicine and Vaccines by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Chicken Medicine and Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Chicken Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Chicken Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Chicken Medicine and Vaccines Revenue Market Share by Type (2021-2026) Table 28. Global Chicken Medicine and Vaccines Revenue Market Share by Type (2027-2032) Table 29. Global Chicken Medicine and Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Chicken Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Chicken Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Chicken Medicine and Vaccines Revenue Market Share by Application (2021-2026) Table 33. Global Chicken Medicine and Vaccines Revenue Market Share by Application (2027-2032) Table 34. CAVAC Company Information Table 35. CAVAC Business Overview Table 36. CAVAC Chicken Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. CAVAC Chicken Medicine and Vaccines Product Portfolio Table 38. CAVAC Recent Development Table 39. CEVA Company Information Table 40. CEVA Business Overview Table 41. CEVA Chicken Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. CEVA Chicken Medicine and Vaccines Product Portfolio Table 43. CEVA Recent Development Table 44. DHN Company Information Table 45. DHN Business Overview Table 46. DHN Chicken Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. DHN Chicken Medicine and Vaccines Product Portfolio Table 48. DHN Recent Development Table 49. Elanco (Lohmann) Company Information Table 50. Elanco (Lohmann) Business Overview Table 51. Elanco (Lohmann) Chicken Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Elanco (Lohmann) Chicken Medicine and Vaccines Product Portfolio Table 53. Elanco (Lohmann) Recent Development Table 54. FATRO Company Information Table 55. FATRO Business Overview Table 56. FATRO Chicken Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. FATRO Chicken Medicine and Vaccines Product Portfolio Table 58. FATRO Recent Development Table 59. Merial Company Information Table 60. Merial Business Overview Table 61. Merial Chicken Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Merial Chicken Medicine and Vaccines Product Portfolio Table 63. Merial Recent Development Table 64. QYH Biotech Company Information Table 65. QYH Biotech Business Overview Table 66. QYH Biotech Chicken Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. QYH Biotech Chicken Medicine and Vaccines Product Portfolio Table 68. QYH Biotech Recent Development Table 69. Ringpu Biology Company Information Table 70. Ringpu Biology Business Overview Table 71. Ringpu Biology Chicken Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Ringpu Biology Chicken Medicine and Vaccines Product Portfolio Table 73. Ringpu Biology Recent Development Table 74. Vaksindo Company Information Table 75. Vaksindo Business Overview Table 76. Vaksindo Chicken Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Vaksindo Chicken Medicine and Vaccines Product Portfolio Table 78. Vaksindo Recent Development Table 79. Yebio Company Information Table 80. Yebio Business Overview Table 81. Yebio Chicken Medicine and Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Yebio Chicken Medicine and Vaccines Product Portfolio Table 83. Yebio Recent Development Table 84. Zoetis Company Information Table 85. Zoetis Business Overview Table 86. Zoetis Chicken Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Zoetis Chicken Medicine and Vaccines Product Portfolio Table 88. Zoetis Recent Development Table 89. ChengDu Tecbond Company Information Table 90. ChengDu Tecbond Business Overview Table 91. ChengDu Tecbond Chicken Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. ChengDu Tecbond Chicken Medicine and Vaccines Product Portfolio Table 93. ChengDu Tecbond Recent Development Table 94. Merck Animal Health Company Information Table 95. Merck Animal Health Business Overview Table 96. Merck Animal Health Chicken Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Merck Animal Health Chicken Medicine and Vaccines Product Portfolio Table 98. Merck Animal Health Recent Development Table 99. Harbin Veterinary Research Institute Company Information Table 100. Harbin Veterinary Research Institute Business Overview Table 101. Harbin Veterinary Research Institute Chicken Medicine and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Harbin Veterinary Research Institute Chicken Medicine and Vaccines Product Portfolio Table 103. Harbin Veterinary Research Institute Recent Development Table 104. North America Chicken Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 105. North America Chicken Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 106. North America Chicken Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 107. North America Chicken Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 108. North America Chicken Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. North America Chicken Medicine and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 110. North America Chicken Medicine and Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 111. Europe Chicken Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 112. Europe Chicken Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 113. Europe Chicken Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 114. Europe Chicken Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 115. Europe Chicken Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. Europe Chicken Medicine and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 117. Europe Chicken Medicine and Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 118. China Chicken Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 119. China Chicken Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 120. China Chicken Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 121. China Chicken Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 122. Asia Chicken Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 123. Asia Chicken Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 124. Asia Chicken Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 125. Asia Chicken Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 126. Asia Chicken Medicine and Vaccines Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Asia Chicken Medicine and Vaccines Revenue by Region (US$ Million) & (2021-2026) Table 128. Asia Chicken Medicine and Vaccines Revenue by Region (US$ Million) & (2027-2032) Table 129. SAMEA Chicken Medicine and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 130. SAMEA Chicken Medicine and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 131. SAMEA Chicken Medicine and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 132. SAMEA Chicken Medicine and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 133. SAMEA Chicken Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. SAMEA Chicken Medicine and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 135. SAMEA Chicken Medicine and Vaccines Revenue by Country (US$ Million) & (2027-2032) Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Chicken Medicine and Vaccines Image Figure 2. Global Chicken Medicine and Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chicken Medicine and Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Medicine Image Figure 5. Vaccines Image Figure 6. Global Chicken Medicine and Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Chicken Medicine and Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Farm Image Figure 9. Government Image Figure 10. Global Chicken Medicine and Vaccines Market Size (US$ Million) & (2021-2032) Figure 11. Global Chicken Medicine and Vaccines Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Chicken Medicine and Vaccines Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Chicken Medicine and Vaccines Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Chicken Medicine and Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Chicken Medicine and Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Chicken Medicine and Vaccines Revenue Market Share by Type (2021-2032) Figure 18. Global Chicken Medicine and Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Chicken Medicine and Vaccines Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Chicken Medicine and Vaccines Revenue Market Share by Application (2021-2032) Figure 21. North America Chicken Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Chicken Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 23. North America Chicken Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 24. North America Chicken Medicine and Vaccines Revenue Share by Country (2021-2032) Figure 25. United States Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Chicken Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Chicken Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 30. Europe Chicken Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 31. Europe Chicken Medicine and Vaccines Revenue Share by Country (2021-2032) Figure 32. Germany Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Chicken Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Chicken Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 42. China Chicken Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 43. Asia Chicken Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Chicken Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 45. Asia Chicken Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 46. Asia Chicken Medicine and Vaccines Revenue Share by Region (2021-2032) Figure 47. Japan Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Chicken Medicine and Vaccines Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Chicken Medicine and Vaccines Revenue Share by Type (2021-2032) Figure 55. SAMEA Chicken Medicine and Vaccines Revenue Share by Application (2021-2032) Figure 56. SAMEA Chicken Medicine and Vaccines Revenue Share by Country (2021-2032) Figure 57. Brazil Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Chicken Medicine and Vaccines Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Medicine
  • Vaccines
Applications
  • Farm
  • Government
Companies covered
  • CAVAC
  • CEVA
  • DHN
  • Elanco (Lohmann)
  • FATRO
  • Merial
  • QYH Biotech
  • Ringpu Biology
  • Vaksindo
  • Yebio
  • Zoetis
  • ChengDu Tecbond
  • Merck Animal Health
  • Harbin Veterinary Research Institute

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Chicken Medicine and Vaccines Market by Type
  3. 1.2.1 Global Chicken Medicine and Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Medicine
  5. 1.2.3 Vaccines
  6. 1.3 Chicken Medicine and Vaccines Market by Application
  7. 1.3.1 Global Chicken Medicine and Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Farm
  9. 1.3.3 Government
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Chicken Medicine and Vaccines Market Dynamics
  1. 2.1 Chicken Medicine and Vaccines Industry Trends
  2. 2.2 Chicken Medicine and Vaccines Industry Drivers
  3. 2.3 Chicken Medicine and Vaccines Industry Opportunities and Challenges
  4. 2.4 Chicken Medicine and Vaccines Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Chicken Medicine and Vaccines Market Perspective (2021-2032)
  2. 3.2 Global Chicken Medicine and Vaccines Growth Trends by Region
  3. 3.2.1 Global Chicken Medicine and Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Chicken Medicine and Vaccines Market Size by Region (2021-2026)
  5. 3.2.3 Global Chicken Medicine and Vaccines Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Chicken Medicine and Vaccines Revenue by Players
  2. 4.1.1 Global Chicken Medicine and Vaccines Revenue by Players (2021-2026)
  3. 4.1.2 Global Chicken Medicine and Vaccines Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Chicken Medicine and Vaccines Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Chicken Medicine and Vaccines Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Chicken Medicine and Vaccines Key Players Headquarters & Area Served
  7. 4.4 Global Chicken Medicine and Vaccines Players, Product Type & Application
  8. 4.5 Global Chicken Medicine and Vaccines Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Chicken Medicine and Vaccines Market CR5 and HHI
  11. 4.6.3 2025 Chicken Medicine and Vaccines Tier 1, Tier 2, and Tier 3
5 Chicken Medicine and Vaccines Market Size by Type
  1. 5.1 Global Chicken Medicine and Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Chicken Medicine and Vaccines Revenue by Type (2021-2032)
  3. 5.3 Global Chicken Medicine and Vaccines Revenue Market Share by Type (2021-2032)
6 Chicken Medicine and Vaccines Market Size by Application
  1. 6.1 Global Chicken Medicine and Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Chicken Medicine and Vaccines Revenue by Application (2021-2032)
  3. 6.3 Global Chicken Medicine and Vaccines Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 CAVAC
  2. 7.1.1 CAVAC Company Information
  3. 7.1.2 CAVAC Business Overview
  4. 7.1.3 CAVAC Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  5. 7.1.4 CAVAC Chicken Medicine and Vaccines Product Portfolio
  6. 7.1.5 CAVAC Recent Developments
  7. 7.2 CEVA
  8. 7.2.1 CEVA Company Information
  9. 7.2.2 CEVA Business Overview
  10. 7.2.3 CEVA Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  11. 7.2.4 CEVA Chicken Medicine and Vaccines Product Portfolio
  12. 7.2.5 CEVA Recent Developments
  13. 7.3 DHN
  14. 7.3.1 DHN Company Information
  15. 7.3.2 DHN Business Overview
  16. 7.3.3 DHN Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  17. 7.3.4 DHN Chicken Medicine and Vaccines Product Portfolio
  18. 7.3.5 DHN Recent Developments
  19. 7.4 Elanco (Lohmann)
  20. 7.4.1 Elanco (Lohmann) Company Information
  21. 7.4.2 Elanco (Lohmann) Business Overview
  22. 7.4.3 Elanco (Lohmann) Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Elanco (Lohmann) Chicken Medicine and Vaccines Product Portfolio
  24. 7.4.5 Elanco (Lohmann) Recent Developments
  25. 7.5 FATRO
  26. 7.5.1 FATRO Company Information
  27. 7.5.2 FATRO Business Overview
  28. 7.5.3 FATRO Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  29. 7.5.4 FATRO Chicken Medicine and Vaccines Product Portfolio
  30. 7.5.5 FATRO Recent Developments
  31. 7.6 Merial
  32. 7.6.1 Merial Company Information
  33. 7.6.2 Merial Business Overview
  34. 7.6.3 Merial Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Merial Chicken Medicine and Vaccines Product Portfolio
  36. 7.6.5 Merial Recent Developments
  37. 7.7 QYH Biotech
  38. 7.7.1 QYH Biotech Company Information
  39. 7.7.2 QYH Biotech Business Overview
  40. 7.7.3 QYH Biotech Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  41. 7.7.4 QYH Biotech Chicken Medicine and Vaccines Product Portfolio
  42. 7.7.5 QYH Biotech Recent Developments
  43. 7.8 Ringpu Biology
  44. 7.8.1 Ringpu Biology Company Information
  45. 7.8.2 Ringpu Biology Business Overview
  46. 7.8.3 Ringpu Biology Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Ringpu Biology Chicken Medicine and Vaccines Product Portfolio
  48. 7.8.5 Ringpu Biology Recent Developments
  49. 7.9 Vaksindo
  50. 7.9.1 Vaksindo Company Information
  51. 7.9.2 Vaksindo Business Overview
  52. 7.9.3 Vaksindo Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Vaksindo Chicken Medicine and Vaccines Product Portfolio
  54. 7.9.5 Vaksindo Recent Developments
  55. 7.10 Yebio
  56. 7.10.1 Yebio Company Information
  57. 7.10.2 Yebio Business Overview
  58. 7.10.3 Yebio Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Yebio Chicken Medicine and Vaccines Product Portfolio
  60. 7.10.5 Yebio Recent Developments
  61. 7.11 Zoetis
  62. 7.11.1 Zoetis Company Information
  63. 7.11.2 Zoetis Business Overview
  64. 7.11.3 Zoetis Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Zoetis Chicken Medicine and Vaccines Product Portfolio
  66. 7.11.5 Zoetis Recent Developments
  67. 7.12 ChengDu Tecbond
  68. 7.12.1 ChengDu Tecbond Company Information
  69. 7.12.2 ChengDu Tecbond Business Overview
  70. 7.12.3 ChengDu Tecbond Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  71. 7.12.4 ChengDu Tecbond Chicken Medicine and Vaccines Product Portfolio
  72. 7.12.5 ChengDu Tecbond Recent Developments
  73. 7.13 Merck Animal Health
  74. 7.13.1 Merck Animal Health Company Information
  75. 7.13.2 Merck Animal Health Business Overview
  76. 7.13.3 Merck Animal Health Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Merck Animal Health Chicken Medicine and Vaccines Product Portfolio
  78. 7.13.5 Merck Animal Health Recent Developments
  79. 7.14 Harbin Veterinary Research Institute
  80. 7.14.1 Harbin Veterinary Research Institute Company Information
  81. 7.14.2 Harbin Veterinary Research Institute Business Overview
  82. 7.14.3 Harbin Veterinary Research Institute Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Harbin Veterinary Research Institute Chicken Medicine and Vaccines Product Portfolio
  84. 7.14.5 Harbin Veterinary Research Institute Recent Developments
8 North America
  1. 8.1 North America Chicken Medicine and Vaccines Revenue (2021-2032)
  2. 8.2 North America Chicken Medicine and Vaccines Revenue by Type (2021-2032)
  3. 8.2.1 North America Chicken Medicine and Vaccines Revenue by Type (2021-2026)
  4. 8.2.2 North America Chicken Medicine and Vaccines Revenue by Type (2027-2032)
  5. 8.3 North America Chicken Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 8.4 North America Chicken Medicine and Vaccines Revenue by Application (2021-2032)
  7. 8.4.1 North America Chicken Medicine and Vaccines Revenue by Application (2021-2026)
  8. 8.4.2 North America Chicken Medicine and Vaccines Revenue by Application (2027-2032)
  9. 8.5 North America Chicken Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 8.6 North America Chicken Medicine and Vaccines Revenue by Country
  11. 8.6.1 North America Chicken Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Chicken Medicine and Vaccines Revenue by Country (2021-2026)
  13. 8.6.3 North America Chicken Medicine and Vaccines Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Chicken Medicine and Vaccines Revenue (2021-2032)
  2. 9.2 Europe Chicken Medicine and Vaccines Revenue by Type (2021-2032)
  3. 9.2.1 Europe Chicken Medicine and Vaccines Revenue by Type (2021-2026)
  4. 9.2.2 Europe Chicken Medicine and Vaccines Revenue by Type (2027-2032)
  5. 9.3 Europe Chicken Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 9.4 Europe Chicken Medicine and Vaccines Revenue by Application (2021-2032)
  7. 9.4.1 Europe Chicken Medicine and Vaccines Revenue by Application (2021-2026)
  8. 9.4.2 Europe Chicken Medicine and Vaccines Revenue by Application (2027-2032)
  9. 9.5 Europe Chicken Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 9.6 Europe Chicken Medicine and Vaccines Revenue by Country
  11. 9.6.1 Europe Chicken Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Chicken Medicine and Vaccines Revenue by Country (2021-2026)
  13. 9.6.3 Europe Chicken Medicine and Vaccines Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Chicken Medicine and Vaccines Revenue (2021-2032)
  2. 10.2 China Chicken Medicine and Vaccines Revenue by Type (2021-2032)
  3. 10.2.1 China Chicken Medicine and Vaccines Revenue by Type (2021-2026)
  4. 10.2.2 China Chicken Medicine and Vaccines Revenue by Type (2027-2032)
  5. 10.3 China Chicken Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 10.4 China Chicken Medicine and Vaccines Revenue by Application (2021-2032)
  7. 10.4.1 China Chicken Medicine and Vaccines Revenue by Application (2021-2026)
  8. 10.4.2 China Chicken Medicine and Vaccines Revenue by Application (2027-2032)
  9. 10.5 China Chicken Medicine and Vaccines Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Chicken Medicine and Vaccines Revenue (2021-2032)
  2. 11.2 Asia Chicken Medicine and Vaccines Revenue by Type (2021-2032)
  3. 11.2.1 Asia Chicken Medicine and Vaccines Revenue by Type (2021-2026)
  4. 11.2.2 Asia Chicken Medicine and Vaccines Revenue by Type (2027-2032)
  5. 11.3 Asia Chicken Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 11.4 Asia Chicken Medicine and Vaccines Revenue by Application (2021-2032)
  7. 11.4.1 Asia Chicken Medicine and Vaccines Revenue by Application (2021-2026)
  8. 11.4.2 Asia Chicken Medicine and Vaccines Revenue by Application (2027-2032)
  9. 11.5 Asia Chicken Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 11.6 Asia Chicken Medicine and Vaccines Revenue by Country
  11. 11.6.1 Asia Chicken Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Chicken Medicine and Vaccines Revenue by Country (2021-2026)
  13. 11.6.3 Asia Chicken Medicine and Vaccines Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Chicken Medicine and Vaccines Revenue (2021-2032)
  2. 12.2 SAMEA Chicken Medicine and Vaccines Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Chicken Medicine and Vaccines Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Chicken Medicine and Vaccines Revenue by Type (2027-2032)
  5. 12.3 SAMEA Chicken Medicine and Vaccines Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Chicken Medicine and Vaccines Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Chicken Medicine and Vaccines Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Chicken Medicine and Vaccines Revenue by Application (2027-2032)
  9. 12.5 SAMEA Chicken Medicine and Vaccines Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Chicken Medicine and Vaccines Revenue by Country
  11. 12.6.1 SAMEA Chicken Medicine and Vaccines Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Chicken Medicine and Vaccines Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Chicken Medicine and Vaccines Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst